Abstract
Reducing Na+ in the extracellular environment may lead to two beneficial effects for increasing agonist binding to cell surface G-protein coupled receptors (GPCRs): reduction of Na+-mediated binding block and reduce of receptor internalization. However, such combined effects have not been explored. We used Chinese Hamster Ovary cells expressing vasopressin V1b receptors as a model to explore Na+ sensitivity in agonist binding and receptor internalization. Under basal conditions, a large fraction of V1b receptors is located intracellularly and a small fraction is in the plasma membrane. Decreases in external Na+ increased cell surface [3H]AVP binding and decreased receptor internalization. Substitution of Na+ by Cs+ or NH4+ inhibited agonist binding. To suppress receptor internalization, the concentration of NaCl, but not of CsCl, had to be less than 50 mM, due to the high sensitivity of the internalization machinery to Na+ over Cs+. Iso-osmotic supplementation of glucose or NH4Cl maintained internalization of the V1b receptor, even in a low-NaCl environment. Moreover, iodide ions, which acted as a counter anion, inhibited V1b agonist binding. In summary, we found external ionic conditions that could increase the presence of high-affinity state receptors at the cell surface with minimum internalization during agonist stimulations.
Similar content being viewed by others
Introduction
G protein-coupled receptors (GPCRs) receive a broad range of information, mediated by diverse agonists binding at the active (orthosteric) sites of the receptor. The affinity of orthosteric agonist binding to GPCRs can be allosterically modulated by the ionic composition of extracellular fluids1. Na+ allosterically inhibits the binding of agonists, but not antagonists, in many class A GPCRs2,3,4. The structural basis of the interactions between GPCRs and Na+ has been demonstrated by the solution structure of the human A2a adenosine receptor at 1.8 angstrom high resolution5. Na+ and the surrounding water molecule network interact with well-preserved amino acids in the Na+-binding pocket, which is created by receptor transmembrane helixes. The introduction of amino acid substitutions to a conserved aspartic acid [Asp2.50 in Ballesteros-Weinstein numbering6] in the second transmembrane domain of neurotensin receptors abrogates the Na+ effect on ligand binding3,7. A comparison between active and inactive A2a receptors has indicated that high-affinity agonist binding disrupts the interaction between the receptor and the Na+-water network5.
In addition to the modulation of agonist binding by Na+, receptor internalization can be regulated by extracellular tonicity and ion conditions. Hypotonic shock and the subsequent reduction in extracellular potassium ion levels effectively depletes intracellular potassium ions and blocks internalization of the receptor for low density lipoprotein (LDL) and epidermal growth factors (EGF), which may be a result of the inhibition of new clathrin pit formation8,9. The molecular mechanism and structural requirements for sensing intracellular potassium in clathrin-coated pit formation are not well-understood. For plasma membrane GPCRs, an activated receptor interacts with the corresponding heterotrimeric G proteins10. The agonist-bound receptors are subsequently phosphorylated, associate with β-arrestin proteins and are internalized by clathrin-dependent and independent mechanisms11. Hyperosmotic conditions produced by high glucose have also been reported to inhibit the internalization of GPCRs and other receptors12. Because Na+ is one of the major determinants of extracellular fluid osmolarity, changing extracellular Na+ levels may alter both the agonist binding and internalization processes in GPCRs. However, the overall effect of changing the levels of extracellular Na+ ions on the internalization of GPCRs in a cellular context has not been examined in detail.
Using the vasopressin V1b receptor expressed in Chinese hamster ovary (CHO) cells as a model, we quantitatively investigated the interaction between the agonist and cell surface receptors and subsequent receptor internalization in a modified extracellular ionic environment composition. Specifically, the effects of decreasing the extracellular Na+ level, replacing Na+ with other monovalent cations, or replacing Na+ with isotonic glucose on both the agonist binding and internalization of the V1b receptors were examined. The posterior pituitary hormone arginine-vasopressin (AVP) is a nonapeptide that strongly promotes water retention in normal and pathological conditions13,14. Neurohormonal stimuli of AVP are perceived by three vasopressin receptor subtypes (V1a, V1b and V2) as well as the oxytocin receptor15,16. V1b receptor expression is found in peripheral endocrine organs, such as the anterior pituitary, pancreatic β-cells and the adrenal medulla. In the central nervous system, the V1b receptor is also expressed in the hippocampus, the paraventricular nucleus and the olfactory bulb regions17. In addition, the V1b receptor is located in the colonic epithelia, where the ionic composition around the cells can be widely altered in physiological and pathophysiological conditions18,19.
Here, we measured [3H]AVP uptake into CHO cells expressing the V1b receptors to evaluate V1b receptor internalization, on the basis of our recent findings that the V1b receptors are distributed in both the cytoplasm and the plasma membrane at resting state and that they extensively internalized agonist when stimulated20. We evaluated agonist binding and internalization under a wide range of external Na+ levels and identified an unexpected robustness of the receptor function in a cellular context.
Results
Agonist binding and internalization of V1b receptors were dependent on extracellular Na+ levels
Agonist binding and receptor internalization by clathrin-coated pits are two important steps dependent on the extracellular NaCl concentration3,21. Using [3H]AVP, agonist binding was evaluated by the radioactivity of [3H]AVP bound to cell surface receptors, whereas receptor internalization was evaluated by the radioactivity of [3H]AVP taken up by CHO cells20. We initially examined the NaCl dependency of agonist binding to the V1b receptor at 4 °C, in which the V1b receptor internalization was inhibited. The binding equilibrium was established by incubating the CHO/V1b cells with 1 nM [3H]AVP in different concentrations of NaCl for 2 hours at 4 °C. An increase in the NaCl concentrations from 0 to 150 mM in the buffer resulted in a decrease in the specific [3H]AVP binding to 37% of the counts measured in 0 mM NaCl (Fig. 1a). Therefore, the V1b receptor was considered to be a suitable model to examine Na+ sensitivity in agonist binding. Washing the cells with acidic buffer effectively removed more than 99% of the counts bound to the cells, when the cells were incubated at 4 °C. This finding indicates that the majority of the radioligands were bound to the cell surface V1b receptor and sensitive to acid washing20.
The cells incubated with [3H]AVP for 2 hours at 4 °C were transferred to 37 °C to examine receptor internalization in the buffer conditions with different concentrations of NaCl. After incubation at 37 °C for 30 min, the radioactivity of [3H]AVP either at the cell surface or in the cytoplasm of CHO/V1b cells was measured. The values were calculated as a percentage relative to the counts of [3H]AVP obtained in the cells incubated at 4 °C with no external NaCl. At the physiological concentration of 135 mM NaCl, a large fraction of the counts (106 ± 8%, n = 5) were from acid-resistant, internalized [3H]AVP (Fig. 1b). Therefore, the V1b receptors undergo extensive internalization during incubation at 37 °C. Because of Na+-dependent blocking of agonist binding, we initially expected that the agonist internalization would be gradually inhibited by increasing the Na+ levels in the buffer. However, we obtained the opposite result: extensive internalization of the V1b receptor was detected in a wide range of NaCl between 50–150 mM (Fig. 1b). When NaCl was below 50 mM, the internalized radioligands sharply decreased and the cell surface ligands increased (Fig. 1b). In terms of the efficiency of signal transduction from activated receptors, NaCl in the external buffer was necessary for IP3 production. In the NaCl-containing buffer, the IP3 level was increased by 100 nM AVP from 6.6 ± 1.2 nM at basal to 13.2 ± 0.7 nM (n = 3). In contrast, in the buffer without NaCl, both the basal and AVP-stimulated IP3 levels were below the detection level (<1 nM).
Sodium ion was preferred compared with cesium ion for the internalization of V1b receptors
We substituted Na+ for Cs+ in the external buffer and examined the AVP binding and internalization in CHO/V1b cells. As shown in Fig. 2a, increasing the CsCl concentration in the binding buffer at 4 °C resulted in the progressive inhibition of [3H]AVP binding, as demonstrated in the NaCl buffer (Figs 1a and 2a). This result suggests that extracellular Na+ can be substituted with Cs+ to inhibit [3H]AVP binding to the V1b receptors. However, in contrast to the stable distribution of the cell surface and internalized ligand in various NaCl concentrations from 50 to 150 mM (Fig. 1b), an increase in the CsCl concentration from 0 to 150 mM in the external buffer resulted in a gradual increase in the [3H]AVP internalization and a contrasting decrease in the cell surface binding (Fig. 2b), whereas the [3H]AVP internalization was almost fully enhanced by increasing the NaCl concentration from 0 to 50 mM. Therefore, Na+ was more effective than Cs+ in promoting receptor internalization (Fig. 2c). Data points for internalized [3H]AVP in the different binding buffers were fitted to Hill’s equation and the NaCl or CsCl concentrations that caused half the maximum internalization were calculated (31 ± 3 and 81 ± 7 mM for NaCl and CsCl, respectively, Fig. 2c). Furthermore, Hill’s co-efficient values (nH) were 3.2 and 2.7 for the NaCl and CsCl buffer, respectively (Fig. 2c), indicating that cooperativity of Na+ is higher than Cs+ in promoting receptor internalization.
In the [3H]AVP binding study using membrane samples from CHO/V1b cells, we examined the direct effect of changing NaCl or CsCl levels on the interaction between agonist and V1b receptors. As shown in Fig. 3a, 150 mM CsCl inhibited [3H]AVP binding to a similar level as 150 mM NaCl. [3H]AVP binding was inhibited by 150 mM of NaCl or CsCl to 44 ± 1 or 52 ± 5 %, respectively (n = 8). In the competition binding experiment as shown in Fig. 3b, [3H]AVP binding to V1b receptors was significantly decreased in the buffer containing 150 mM NaCl or CsCl. At 0 M AVP, the specific binding was reduced to 59 and 53% in the NaCl- and CsCl-containing buffers, respectively. On the other hand, no apparent change in the IC50 values was detected. A reduction in the radiolabeled agonist binding by Na+ has previously been reported in opioid receptors22. The non-competitive mode of inhibition of agonist binding by Na+ and Cs+ suggests an allosteric effect on V1b receptors.
Osmolarity is a critical determinant for the internalization of V1b receptors
The change in either NaCl or CsCl concentration causes an alteration in the osmolarity of the binding buffer. In the experiments shown in Figs 1 and 2, the change in the osmolarity in the external buffer was not compensated. When glucose was supplemented in the external buffer to maintain osmolarity at a constant value of 300 mOsm, the cell surface [3H]AVP binding at 4 °C remained inhibited by the increased concentrations of NaCl (Fig. 4a). However, at 37 °C, the counts from the cell surface and internalized [3H]AVP were constant in a wide range of NaCl from 0 to 150 mM, when the osmolarity was maintained constant (Fig. 4b). Therefore, buffer osmolarity is a critical factor for V1b receptor internalization and sensitivity to extracellular NaCl concentrations in a cellular context.
NH4+ substituted Na+ for the internalization of V1b receptors
When NaCl in the binding buffer was substituted with NH4Cl, with the osmolarity of the external buffer maintained at a constant level of 300 mOsm, the inhibition of [3H]AVP binding to the cell surface V1b receptors was maintained at all tested concentrations between 0 mM NH4Cl (150 mM NaCl) and 150 mM NH4Cl (0 mM NaCl; Fig. 5a). Therefore, in contrast to glucose, both Na+ and NH4+ inhibited the [3H]AVP binding to the cell surface receptor. By comparing the degree of inhibition between 0 mM NH4Cl (150 mM NaCl) and 150 mM NH4Cl (0 mM NaCl), we found that the inhibitory effect of NH4+ on agonist binding was greater than that of Na+. (Fig. 5a). At 37 °C, increasing the NH4Cl concentration resulted in a small but significant decrease in the internalized [3H]AVP; however, the cell surface binding for [3H]AVP was not altered (Fig. 5b).
Effects of anions for the agonist binding and internalization of V1b receptors
We further investigated whether different anions in the external buffer have an influence on agonist binding and receptor internalization, although the anion binding site has not been defined in structural studies of GPCRs. To examine the effects of changing the anion composition, we implemented cesium salts, instead of sodium salts, to exclude the potent promoting effect of Na+ on the agonist-induced internalization. The specific counts of [3H]AVP associated with the CHO/V1b cells, which were composed of cell surface and internalized agonists, were smaller in 150 mM CsBr, CsCl or CsI compared with those in 150 mM NaCl (Fig. 6a, black bars), which was mainly because of decreases in the internalized counts in the CsBr, CsCl or CsI buffer compared with the NaCl buffer (Fig. 6a, gray bars). The amount of [3H]AVP associated with the cell surface receptors was not significantly altered (Fig. 6a, white bars). Furthermore, the acid resistant, internalized counts were further decreased in the buffer containing 150 mM CsI compared with the CsCl or CsBr buffer (Fig. 6a, gray bars). Therefore, internalization of the V1b receptors was dependent on not only the Na+ levels but also the I− levels in the external buffer. Substitution of Na+ to Mg2+ did not change the agonist binding or agonist-mediated internalization of the V1b receptors (Fig. 6a). In the experiment using radioligand binding to membrane preparations, changing the buffer composition from CsCl to CsI while maintaining a constant overall cesium salt concentration of 150 mM, resulted in a decrease in the [3H]AVP binding (Fig. 6b). At 150 mM CsI, the specific [3H]AVP binding to membrane preparations from CHO/V1b cells decreased to 4% of the binding detected in 150 mM CsCl (n = 3). The IC50 value of CsI was 50 ± 2 mM. These findings indicated that anion species in the buffer are the critical determinants of [3H]AVP binding to the V1b receptors.
Effects of KCl on the agonist binding and internalization of V1b receptors
Finally, we examined the effect of reducing KCl in the external buffer on the agonist binding and internalization of V1b receptors. As shown in Fig. 7, a decrease in the external K+ levels had no apparent effect on the agonist counts; however, the cellular localization of the V1b receptor (cell surface or cytoplasm) had a significant effect in a two-way ANOVA analysis (P = 0.7 for KCl concentration; P < 0.01 for cellular localization of V1b receptors, surface/intracellular; no interaction was identified between the KCl concentration and cellular localization). Therefore, in our experimental conditions, extracellular Na+ has a more profound effect on V1b receptor internalization compared with K+.
Discussion
We searched for ionic and osmolar conditions in the external buffer that enabled efficient agonist binding to GPCRs and reduced receptor internalization. V1b receptors in CHO cells serve as an ideal model for investigating this topic, because in the unstimulated state, only a small fraction of the V1b receptor is located in the plasma membrane and a substantial fraction of the receptor is in the cytoplasm. In addition, the cell surface V1b receptors extensively internalize upon agonist binding. Therefore, it is difficult to characterize V1b receptors in a cellular context. At a physiological concentration of 135 mM NaCl in the external buffer (Fig. 1b), the fraction of internalized agonist reached 106% of the initial cell surface receptor, suggesting that the V1b receptor that initially resided in the intracellular space was inserted to the plasma membrane and further internalized following agonist binding20. This extensive internalization of the V1b receptors was maintained in a wide range of external NaCl concentrations (50–150 mM). At NaCl concentrations of less than 50 mM, agonist binding to the cell surface V1b receptors was sharply increased with the reduction of the Na+-mediated binding blocking (Fig. 1b). Therefore, the change in external Na+ concentration had a significant impact on the amount and kinetics of agonist binding to the cell surface V1b receptors. One interesting and new finding in the current study is the preference of Na+ to Cs+ in the external buffer preceding V1b receptor internalization. In addition to ionic compositions, osmolarity is a critical determinant for V1b receptor internalization. Furthermore, we found that I− inhibited agonist binding to the V1b receptors.
[3H]AVP binding to the cell surface V1b receptor was inhibited by increasing the Na+ level in the external buffer. The aspartic acid in the second transmembrane domain, Asp2.50, plays a critical role in Na+-mediated blocking of agonist binding to many class A GPCRs3. This aspartic acid is conserved among all members of the vasopressin/oxytocin receptor family including the V1b receptors. It has been reported that the extent of Na+-dependent inhibition of agonist binding differs depending on the receptor examined. In human histamine receptors, the activity of the H3-receptor (hH3R) is sensitive to Na+; however, the constitutive and agonist-dependent activity of hH4R is not23. Agonist binding to the Y1 subtype neuropeptide Y receptor is selectively enabled by Ca2+ and strongly attenuated by Na+ and other alkali monovalent cations, whereas monovalent cations including Na+ up to 100 mM stimulate the agonist binding to Y2 receptors and inhibit binding at higher concentrations24,25. Therefore, it is important to experimentally define the Na+ effect in each receptor.
A reduction in the NaCl concentration below 50 mM in the binding buffer without compensation of osmolarity decreased the V1b receptor internalization. Maintaining the osmolarity at a physiological level by supplying glucose or NH4Cl in a low-NaCl buffer caused the recovery of receptor internalization. However, glucose did not substitute for the role of NaCl in terms of the Na+-mediated inhibition of the agonist binding. Extensive internalization of V1b receptors and accumulation of radiolabeled agonist in the cells enabled the internalization assay of V1b receptors in good signal-to-noise ratio. On the other hand, the internalization of V1a receptors is less extensive compared with V1b receptors from our previous analysis20. Moreover, internalized V1a receptors rapidly recycle to the plasma membrane26. V2 receptors internalize for a longer period than V1a receptors; however, internalized fraction was approximately 30% of initial cell surface count26. We demonstrated that extensive internalization of V1b receptors is based on the sensitivity to Na+ ions. The robustness of the V1b receptor internalization was observed when external buffer contained reduced concentrations of Na+ but not Cs+. In previous reports, hypotonic shock and the subsequent treatment of a cell with low-potassium buffer has been demonstrated to inhibit internalization of LDL- or EGF-bound receptors8. Intracellular potassium is necessary for formation of new coated pits, whereas already assembled coated pits can internalize receptor-bound LDL9. In the protocol for the sequential treatment of hypotonic shock and low-potassium buffer, the osmolarity of the hypotonic buffer was reduced to half of the physiological culture medium9. We demonstrated that the hypotonic condition, which was produced by reducing Na+ concentration, was sufficient to inhibit V1b receptor internalization and the treatment of cells in the low-potassium buffer was not necessary. Furthermore, decreasing NaCl concentration in the external environment decreased the internalization of the V1b receptors, despite the increased agonist binding to the cell surface receptor. The increase in the cell surface receptor without internalization by lowering external medium osmolarity (<50 mM NaCl) may have practical implications for efficient drug screening of hydrophilic candidates with agonist activity.
We demonstrated that extracellular Na+ is more effective than Cs+ in promotion of receptor internalization (Fig. 2c). Many reports have described chemical and genetic tools that control clathrin-mediated internalization27. To the best of our knowledge, this investigation is the first study that demonstrates clear preference for Na+ compared with Cs+ in agonist-mediated internalization of a member of the GPCR family. Na+-mediated promotion of the internalization of the V1b receptor was not a result of the increase of agonist binding to the V1b receptors; our experiments on [3H]AVP binding using membrane preparation and whole cells revealed that inhibitory effects on the agonist binding were comparable between NaCl- and CsCl-containing buffers. In contrast, previous work has demonstrated that the influence of Na+ on opiate receptor binding is highly specific22. The inhibition of opioid agonist binding by Na+ was mimicked only with Li+, but not with alkali ions with larger ionic radii22. We selected CsCl to compare with NaCl, because the ionic radius of Cs+ is reportedly the largest among stable alkali monovalent cations28. We found that the Na+ binding site in the V1b receptor does not recognize the difference between Na+ and Cs+, in contrast to the mechanism for Na+-mediated promotion of internalization. The molecular identity of the preference for Na+ over Cs+ is currently speculative. A structural study of the inactive and active-like states of A2A adenosine receptors has suggested that the Na+ binding pocket is collapsed in agonist-bound receptors. This suggests that agonist-bound receptors, which proceed to internalization, may not be relevant for Na+ sensitivity during the internalization process.
Hypotonicity changed the cellular distribution of the V1b receptors in the plasma membrane and the cytoplasm. In a previous report, osmotic cell-swelling in the hypotonic environment has been shown to increase cell surface area in intestine 407 cells, as well as increase their subsequent uptake of tetramethylrhodamine isothiocyanate (TRITC)-dextran29. The preceding increase in cell surface area is due to an increase in exocytosis regulated by ATP that was released to extracellular space by hypotonic shock29,30,31. Extracellular ATP can act in both an autocrine and paracrine manner to stimulate purinergic receptors, P2Y GPCRs or P2X ligand-gated ion channels, leading to an increase in the phosphorylated form of ERKs29,32. Subtypes of the P2Y receptor are known to couple with Gq/11 proteins, as do the V1b receptors. It is tempting to speculate that the Gq/11-coupled V1b receptors might use the same signaling cascade as ATP to regulate receptor internalization and recycling. Future studies should elucidate whether ATP could add further regulation to the cellular trafficking of the agonist-stimulated V1b receptors.
Monovalent anions were found to have a significant inhibitory impact on AVP binding to the V1b receptors. We selected cesium salts to examine a possible role of anions in agonist binding and internalization because Na+ significantly promotes receptor internalization and may obscure differences among anions. Our analysis revealed that I−, but not Br−, reduced [3H]AVP internalization. Moreover, increasing the concentration ratio of CsI/CsCl in the binding buffer while keeping the total cesium salts at 150 mM resulted in the inhibition of specific [3H]AVP binding. Therefore, we concluded that I− has a large inhibitory impact on the binding of AVP to V1b receptors and the subsequent internalization.
The role of I− in receptor-effector coupling has been reported in previous studies. Agonist stimulation of the β2-adrenergic receptor enhances adenylate cyclase activity more efficiently in NaI buffer compared with NaCl buffer33. There is a strong linear correlation between the anion radius and the efficiency of sodium salts for enhancing the adenylate cyclase33. For CXCR4 chemokine receptors, maximum response and agonist potency in GTP hydrolysis are decreased more in NaI buffer than in NaCl buffer34. Iodide ions may increase the affinity of GDP to interact with Gi protein, which results in inefficient GDT-GTP exchange34. Furthermore, NaI inhibits signaling via H3 histamine receptors and binding of GPTγS to δ-opioid-Gi fusion receptors35,36. We identified strong inhibitory effects of I− on agonist binding to the V1b receptor. It has been known that coupling between the receptor and GTP-bound form of Gα-proteins usually decreases the affinity of the agonist37. Further investigation is necessary to clarify whether I− inhibits the GTPase activity of Gα-proteins coupled with the V1b receptors and increases the GTP-bound form of Gα-proteins. Although the mechanism of I–mediated inhibition of agonist binding to the V1b receptor is not clear at present, the use of buffer containing Cs salts was effective to elucidate the effects of each anion on the agonist binding to V1b receptors.
Our findings indicate that the buffer compositions for optimal V1b receptor binding and internalization are different from the buffer compositions for promoting transferrin internalization in reticulocytes38. Approximately 50–80 mM NaCl in the buffer is necessary to reach a submaximal internalization of both iron-bound transferrin and AVP bound to the V1b receptors38. However, NH4Cl cannot substitute for NaCl in the transferrin internalization; the level of iron internalization does not increase with a rise in NH4Cl concentration in NaCl-reduced buffer38. In V1b-mediated internalization, 50% of the total counts associated with the cells were from the internalized ligand in 150 mM NH4Cl compared with 67% in 150 mM NaCl (Fig. 5). Together with the result that NH4+ can be substituted with Na+ for inhibition of AVP binding, the role of NH4+ in V1b receptor-mediated internalization is different from the role in transferrin-mediated internalization. Additionally, sucrose cannot be substituted with NaCl in transferrin internalization in contrast to V1b receptor internalization38. Therefore, a different external environment appears to be necessary for the internalization of the V1b receptor in the GPCR family compared with the internalization of the transferrin receptor of the single-transmembrane receptor family39.
In summary, external ionic conditions have substantial impacts on agonist binding and V1b receptor internalization, which have not been previously recognized. A reduction in the NaCl concentrations increased cell surface binding mainly because of the following two reasons: an increase in the agonist affinity and a decrease in the receptor internalization in CHO/V1b cells. The mechanism of Na+-sensitive receptor internalization should be further investigated.
Methods
Materials
Construction of the expression plasmid containing a coding sequence of the mouse V1b receptor was described previously40. Chinese hamster ovary (CHO)-derived cells were obtained from the American Type Culture Collection (Rockville, MD, USA). Reagent grade chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan). [3H]AVP (61.2 Ci/mmol) was purchased from PerkinElmer Japan (Yokohama, Japan).
Cell culture and transfection
CHO cells were cultured in Ham’s F12 medium supplemented with heat-inactivated 10% fetal calf serum (Life Technologies Japan, Tokyo, Japan), 100 U/mL penicillin and 100 g/mL streptomycin at 37 °C in 5% CO2 in an air-ventilated humidified incubator. Production of CHO cell lines that stably express V1b receptors (CHO/V1b) was described previously20,41. Briefly, one day after seeding the 1 × 105 cells in a 100-mm cell culture dish, the medium was supplemented with a mixture of 0.7 mL of serum-free F12 medium, 21 μL of FuGene 6 transfection reagent (Promega, Tokyo, Japan) and 7 μg of the plasmid DNA and the cells were cultured for 24 hours. The cells were collected with 0.025% trypsin and 0.01% EDTA treatment and seeded at 1 × 104 cells in 100-mm tissue culture dishes. Single colonies that were resistant to the treatment of 0.2 mg/mL zeocin (Thermo Fisher Scientific, Waltham, MA, USA) were isolated and maintained in the same selection medium. The expression of the transfected receptors was screened using intracellular Ca2+ measurement42. We previously reported the expression levels and agonist affinity of the V1b receptors in this cell line (Bmax = 645 ± 53 fmol/mg protein and Kd = 1.8 ± 0.7 nM)20.
Radioligand binding
In 12-well dishes, cells were plated at a density of 1 × 105 cells/well, incubated for 24 hours and used for a radioligand binding assay20,41. For the saturation binding studies, the cells were washed once with ice-cold Ham’s F-12 medium and incubated for 2 hours on ice with 10–10000 pM of [3H]AVP in buffer C [Ham’s F-12 medium containing 50 mM HEPES (pH = 7.4), 0.3% bovine serum albumin]. The cells were then washed 3 times with buffer B (50 mM Tris-HCl, pH = 7.4, 10 mM MgCl2 and 0.3% bovine serum albumin), collected with 0.5 mL of 0.1 N NaOH and mixed with 4 mL of the scintillation cocktail (ULTIMA GoldTM, PerkinElmer, MA, USA). The total binding sites and Kd values were calculated using the nonlinear curve-fitting computer program Igor (WaveMetrics, Lake Oswego, OR, USA). There was no detectable specific binding or uptake of [3H]AVP for the wild-type CHO cells (see Supplemental Figure SF1).
To measure receptor internalization, cells in 12-well culture plates were treated with 1 nM [3H]AVP in assay buffer [10 mM HEPES (pH = 7.4), 5 mM KCl, 1.2 mM CaCl2, 1 mM MgCl2 and 10 mM glucose] containing various concentrations of NaCl and/or glucose for 2 hours at 4 °C. The culture plates were subsequently incubated at 37 or 4 °C for 30 min. Following the incubations, all plates were washed three times with ice-cold neutral buffer at 4 °C to remove excess [3H]AVP. [3H]AVP bound to cell surface receptors was removed by acid washing with ice-cold acidic buffer (50 mM sodium acetate and 150 mM NaCl, pH = 3) for 5 min at 4 °C43. The remaining counts following the acid wash were considered to come from internalized [3H]AVP.
Membrane samples for the radioligand binding study were prepared from culture cells as previously described44. For the saturation binding studies, 25 μg of the membrane samples were incubated with 50–10000 pM [3H]AVP for 60 min at 25 °C in 400 μL of binding buffer B. At the end of the incubation period, 1 mL of ice-cold buffer B was added and the samples were filtered through a glass fiber membrane (type GF/B, GE Healthcare UK Ltd., UK). After three washes with buffer B, the filters were soaked in 4 mL of liquid scintillation cocktail and the membrane-bound radioactivity was measured. The nonspecific radioligand binding was determined in the presence of 1 μM AVP.
Data analysis
All values in the text are reported as the mean ± SEM. In several data points in the Figures, the errors are so small that the error bars are behind the symbol. Significant differences were determined by Student’s t-test or ANOVA followed by a multiple comparison test with Holm’s adjustment. The statistics were calculated using the statistical computer program R [R Core Team (2015). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria].
Additional Information
How to cite this article: Koshimizu, T.-a. et al. Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors. Sci. Rep. 6, 25327; doi: 10.1038/srep25327 (2016).
References
Christopoulos, A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1, 198–210 (2002).
Pert, C. B., Pasternak, G. & Snyder, S. H. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182, 1359–1361 (1973).
Katritch, V. et al. Allosteric sodium in class A GPCR signaling. Trends Biochem Sci 39, 233–244 (2014).
Gutierrez-de Teran, H. et al. The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor. Structure 21, 2175–2185 (2013).
Liu, W. et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232–236 (2012).
Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G-protein coupled receptors. In Methods Neurosci, vol. 25, 366–428 (Elsevier, 1995).
Martin, S., Botto, J. M., Vincent, J. P. & Mazella, J. Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Mol Pharmacol 55, 210–215 (1999).
Larkin, J. M., Brown, M. S., Goldstein, J. L. & Anderson, R. G. Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts. Cell 33, 273–285 (1983).
Larkin, J. M., Donzell, W. C. & Anderson, R. G. Potassium-dependent assembly of coated pits: new coated pits form as planar clathrin lattices. J Cell Biol 103, 2619–2627 (1986).
Audet, M. & Bouvier, M. Restructuring G-protein- coupled receptor activation. Cell 151, 14–23 (2012).
Luttrell, L. M. & Gesty-Palmer, D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62, 305–330 (2010).
Daukas, G. & Zigmond, S. H. Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes. J Cell Biol 101, 1673–1679 (1985).
Frank, E. & Landgraf, R. The vasopressin system–from antidiuresis to psychopathology. Eur J Pharmacol 583, 226–242 (2008).
Laycock, J. F. Perspectives on Vasopressin (World Scientific Publishing Company, 2010).
Koshimizu, T. A. et al. Vasopressin V1a and V1b receptors: from molecules to physiological systems. Physiological Reviews 92, 1813–1864 (2012).
Juul, K. V., Bichet, D. G., Nielsen, S. & Norgaard, J. P. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Am J Physiol Renal Physiol 306, F931–40 (2014).
Young, W. S., Li, J., Wersinger, S. R. & Palkovits, M. The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience 143, 1031–1039 (2006).
Ventura, M. A., Rene, P., de Keyzer, Y., Bertagna, X. & Clauser, E. Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor. J Mol Endocrinol 22, 251–260 (1999).
Ferrier, L. et al. Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD. Am J Physiol Gastrointest Liver Physiol 299, G1298–307 (2010).
Kashiwazaki, A. et al. Subcellular localization and internalization of the vasopressin V receptor. Eur J Pharmacol 765, 291–299 (2015).
Heuser, J. E. & Anderson, R. G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108, 389–400 (1989).
Pert, C. B. & Snyder, S. H. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Molecular Pharmacology 10, 868–879 (1974).
Schneider, E. H. & Seifert, R. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands. Biochem Pharmacol 78, 607–616 (2009).
Parker, M. S., Parker, S. L. & Kane, J. K. Internalization of neuropeptide Y Y1 and Y5 and of pancreatic polypeptide Y4 receptors is inhibited by lithium in preference to sodium and potassium ions. Regul Pept 118, 67–74 (2004).
Parker, M. S., Crowley, W. R. & Parker, S. L. Differences in cation sensitivity of ligand binding to Y1 and Y2 subtype of neuropeptide Y receptor of rat brain. Eur J Pharmacol 318, 193–200 (1996).
Innamorati, G., Le, G. C., Balamotis, M. & Birnbaumer, M. The long and the short cycle. alternative intracellular routes for trafficking of g-protein-coupled receptors. The Journal of biological chemistry 276, 13096–103 (2001).
Dutta, D. & Donaldson, J. G. Search for inhibitors of endocytosis: Intended specificity and unintended consequences. Cell Logist 2, 203–208 (2012).
Shannon, R. D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallographica Section A 32, 751–767 (1976).
van der Wijk, T., Tomassen, S. F., Houtsmuller, A. B., de Jonge, H. R. & Tilly, B. C. Increased vesicle recycling in response to osmotic cell swelling. Cause and consequence of hypotonicity-provoked ATP release. J Biol Chem 278, 40020–40025 (2003).
Wang, Y., Roman, R., Lidofsky, S. D. & Fitz, J. G. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci USA 93, 12020–12025 (1996).
Taylor, A. L. et al. Bioluminescence detection of ATP release mechanisms in epithelia. Am J Physiol 275, C1391–406 (1998).
Sadoshima, J., Qiu, Z., Morgan, J. P. & Izumo, S. Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes. EMBO J 15, 5535–5546 (1996).
Seifert, R. Monovalent anions differentially modulate coupling of the beta2-adrenoceptor to G(s)alpha splice variants. J Pharmacol Exp Ther 298, 840–847 (2001).
Kleemann, P., Papa, D., Vigil-Cruz, S. & Seifert, R. Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G (o)-proteins in Sf9 insect cells. Naunyn Schmiedebergs Arch Pharmacol 378, 261–274 (2008).
Schnell, D. & Seifert, R. Modulation of histamine H(3) receptor function by monovalent ions. Neurosci Lett 472, 114–118 (2010).
Vosahlikova, M., Jurkiewicz, P., Roubalova, L., Hof, M. & Svoboda, P. High- and low-affinity sites for sodium in delta-OR-Gi1alpha (Cys (351)-Ile (351)) fusion protein stably expressed in HEK293 cells; functional significance and correlation with biophysical state of plasma membrane. Naunyn Schmiedebergs Arch Pharmacol 387, 487–502 (2014).
Lefkowitz, R. J., Mullikin, D. & Caron, M. G. Regulation of beta-adrenergic receptors by guanyl-5′-yl imidodiphosphate and other purine nucleotides. J Biol Chem 251, 4686–4692 (1976).
Paterson, S. & Morgan, E. H. Effect of changes in the ionic environment of reticulocytes on the uptake of transferrin-bound iron. J Cell Physiol 105, 489–502 (1980).
Tortorella, S. & Karagiannis, T. C. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy. J Membr Biol 247, 291–307 (2014).
Oshikawa, S., Tanoue, A., Koshimizu, T. A., Kitagawa, Y. & Tsujimoto, G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol Pharmacol 65, 623–629 (2004).
Arai, K. et al. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide. Eur J Pharmacol 749, 98–106 (2015).
Koshimizu, T. A., Fujiwara, Y., Sakai, N., Shibata, K. & Tsuchiya, H. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci 86, 455–460 (2010).
Haigler, H. T., Maxfield, F. R., Willingham, M. C. & Pastan, I. Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. J Biol Chem 255, 1239–1241 (1980).
Shibata, K. et al. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol 48, 250–258 (1995).
Acknowledgements
We would like to thank Ms. Yuki Oyama for her technical assistance and Ms. Michiko Hashimoto for her secretarial work. This work was supported, in part, by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan and the Promotion and Mutual Aid Corporation for Private Schools of Japan.
Author information
Authors and Affiliations
Contributions
T.-a.K. wrote the main manuscript text. T.-a.K. and A.K. performed the experiments. T.-a.K. and J.T. evaluated the data and prepared all figures. All authors have reviewed the manuscript.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Electronic supplementary material
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Koshimizu, Ta., Kashiwazaki, A. & Taniguchi, J. Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors. Sci Rep 6, 25327 (2016). https://doi.org/10.1038/srep25327
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep25327
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.